Physiological and immunological barriers in the lung
- PMID: 38451292
- PMCID: PMC11136722
- DOI: 10.1007/s00281-024-01003-y
Physiological and immunological barriers in the lung
Abstract
The lungs serve as the primary organ for respiration, facilitating the vital exchange of gases with the bloodstream. Given their perpetual exposure to external particulates and pathogens, they possess intricate protective barriers. Cellular adhesion in the lungs is robustly maintained through tight junctions, adherens junctions, and desmosomes. Furthermore, the pulmonary system features a mucociliary clearance mechanism that synthesizes mucus and transports it to the outside. This mucus is enriched with chemical barriers like antimicrobial proteins and immunoglobulin A (IgA). Additionally, a complex immunological network comprising epithelial cells, neural cells, and immune cells plays a pivotal role in pulmonary defense. A comprehensive understanding of these protective systems offers valuable insights into potential pathologies and their therapeutic interventions.
Keywords: Asthma; Immunological barriers; Lung; Physiological barriers.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Oscillating devices for airway clearance in people with cystic fibrosis.Cochrane Database Syst Rev. 2017 May 4;5(5):CD006842. doi: 10.1002/14651858.CD006842.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Apr 30;4:CD006842. doi: 10.1002/14651858.CD006842.pub5. PMID: 28471492 Free PMC article. Updated.
-
Exercise versus airway clearance techniques for people with cystic fibrosis.Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2. Cochrane Database Syst Rev. 2022. PMID: 35731672 Free PMC article.
-
Silicon Carbide Nanowires Impair Mucociliary Clearance-Mediated Innate Immunity in Primary Human Bronchial Epithelial Cells.ACS Nano. 2025 Jun 17;19(23):21426-21445. doi: 10.1021/acsnano.5c01981. Epub 2025 Jun 6. ACS Nano. 2025. PMID: 40474814 Free PMC article.
-
Airway clearance techniques compared to no airway clearance techniques for cystic fibrosis.Cochrane Database Syst Rev. 2023 Apr 12;4(4):CD001401. doi: 10.1002/14651858.CD001401.pub4. Cochrane Database Syst Rev. 2023. PMID: 37042825 Free PMC article.
-
Inhaled mannitol for cystic fibrosis.Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 May 1;5:CD008649. doi: 10.1002/14651858.CD008649.pub4. PMID: 29424930 Free PMC article. Updated.
Cited by
-
Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections.Infect Dis Rep. 2024 Nov 28;16(6):1127-1181. doi: 10.3390/idr16060092. Infect Dis Rep. 2024. PMID: 39728014 Free PMC article. Review.
-
Inflammatory Profiles Induced by Intranasal Immunization with Ricin Toxin-immune Complexes.Immunohorizons. 2024 Jun 1;8(6):457-463. doi: 10.4049/immunohorizons.2400007. Immunohorizons. 2024. PMID: 38922287 Free PMC article.
-
Shared Genes and Pathways in Ulcerative Colitis and Ankylosing Spondylitis: Functional Validation and Implications for Diagnosis.J Inflamm Res. 2025 Feb 4;18:1657-1678. doi: 10.2147/JIR.S497201. eCollection 2025. J Inflamm Res. 2025. PMID: 39925932 Free PMC article.
-
Respiratory diseases and gut microbiota: relevance, pathogenesis, and treatment.Front Microbiol. 2024 Jul 16;15:1358597. doi: 10.3389/fmicb.2024.1358597. eCollection 2024. Front Microbiol. 2024. PMID: 39081882 Free PMC article. Review.
-
Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models.Pharmaceuticals (Basel). 2025 Jan 31;18(2):195. doi: 10.3390/ph18020195. Pharmaceuticals (Basel). 2025. PMID: 40006008 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous